Sivik Global Healthcare’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-70,000
| Closed | -$5.15M | – | 39 |
|
2025
Q1 | $5.15M | Buy |
+70,000
| New | +$5.15M | 2.78% | 20 |
|
2020
Q3 | – | Sell |
-60,000
| Closed | -$9.21M | – | 43 |
|
2020
Q2 | $9.21M | Sell |
60,000
-15,000
| -20% | -$2.3M | 3.05% | 12 |
|
2020
Q1 | $10.1M | Sell |
75,000
-50,000
| -40% | -$6.76M | 4% | 7 |
|
2019
Q4 | $6.23M | Buy |
125,000
+45,000
| +56% | +$2.24M | 2.31% | 20 |
|
2019
Q3 | $3.57M | Sell |
80,000
-20,000
| -20% | -$892K | 1.8% | 31 |
|
2019
Q2 | $4.13M | Sell |
100,000
-50,000
| -33% | -$2.06M | 1% | 29 |
|
2019
Q1 | $6.07M | Buy |
150,000
+14,600
| +11% | +$590K | 2.23% | 15 |
|
2018
Q4 | $5.14M | Buy |
135,400
+10,400
| +8% | +$395K | 2.77% | 15 |
|
2018
Q3 | $4.95M | Sell |
125,000
-25,000
| -17% | -$989K | 1.77% | 26 |
|
2018
Q2 | $5.27M | Buy |
+150,000
| New | +$5.27M | 2.03% | 22 |
|
2017
Q2 | – | Sell |
-125,000
| Closed | -$3.89M | – | 68 |
|
2017
Q1 | $3.89M | Sell |
125,000
-145,000
| -54% | -$4.52M | 1.81% | 29 |
|
2016
Q4 | $7.38M | Buy |
270,000
+70,000
| +35% | +$1.91M | 3.52% | 5 |
|
2016
Q3 | $6.57M | Buy |
200,000
+90,000
| +82% | +$2.96M | 3.31% | 9 |
|
2016
Q2 | $3.32M | Buy |
+110,000
| New | +$3.32M | 1.65% | 33 |
|